A study to examine the side effects and benefits during marketing phase of Hetero - Bevacizumab in cancer patients
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary outcome(s): Incidence, severity, outcome, duration, action taken, and causality of individual adverse events [Expected and Unexpected adverse events (Serious and Non-serious Adverse Events)] reported during the studyTimepoint: All time points
创建时间：
2018-04-15
